BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 1031729)

  • 1. [How and in which cases can secondary ureteral tumors be prevented?].
    Cuypers L
    J Urol Nephrol (Paris); 1976; 82 Suppl 2():291-4. PubMed ID: 1031729
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: Should patients with primary upper urinary tract cancer receive prophylactic intravesical chemotherapy after nephroureterectomy?: W. J. Wu, H. L. Ke, Y. H. Yang, C. C. Li, Y. H. Chou and C. H. Huang J Urol 2010; 183: 56-61.
    Mouracade P
    J Urol; 2010 Oct; 184(4):1571. PubMed ID: 20728904
    [No Abstract]   [Full Text] [Related]  

  • 3. [Early bladder recurrence after total nephro-urectomy for ureteral tumor].
    Delforges P
    Bull Mem Soc Chir Paris; 1973; 63(3-4):163-6. PubMed ID: 4803443
    [No Abstract]   [Full Text] [Related]  

  • 4. Editorial comment.
    Nieder AM
    J Urol; 2010 Jan; 183(1):61. PubMed ID: 19913834
    [No Abstract]   [Full Text] [Related]  

  • 5. Re: Morgan Rouprêt, Marko Babjuk, Eva Compérat, et al. European Association of Urology Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma: 2015 Update. Eur Urol 2015;68:868-79.
    Shibing Y; Qiang W
    Eur Urol; 2016 Mar; 69(3):e49-50. PubMed ID: 26461110
    [No Abstract]   [Full Text] [Related]  

  • 6. Modified pluck method in en bloc nephroureterectomy with bladder cuff for upper urothelial cancer.
    Hayashi M; Tanaka G; Okutani T
    Int J Urol; 2005 Jun; 12(6):539-43. PubMed ID: 15985074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reply to Yan Shibing and Wei Qiang's Letter to the Editor re: Morgan Rouprêt, Marko Babjuk, Eva Compérat, et al. European Association of Urology Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma: 2015 Update. Eur Urol 2015;68:868-79.
    Rouprêt M
    Eur Urol; 2016 Mar; 69(3):e51-2. PubMed ID: 26461109
    [No Abstract]   [Full Text] [Related]  

  • 8. [Recurrent urothelial cancer after resection of ureteral carcinoma].
    Kong C; Ci J; Liu T
    Zhonghua Zhong Liu Za Zhi; 1998 Nov; 20(6):465-7. PubMed ID: 10920948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radical laparoscopic nephroureterectomy for upper urinary tract transitional cell carcinoma: current status.
    Matin SF
    BJU Int; 2005 Mar; 95 Suppl 2():68-74. PubMed ID: 15720338
    [No Abstract]   [Full Text] [Related]  

  • 10. Stripping technique for endoscopic management of distal ureter during nephroureterectomy: experience of 32 procedures.
    Giovansili B; Peyromaure M; Saïghi D; Dayma T; Zerbib M; Debré B
    Urology; 2004 Sep; 64(3):448-52; discussion 452. PubMed ID: 15351567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Re: Ching-Chia Li, Tu-Hao Chang, Wen-Jeng Wu, et al. Significant predictive factors for prognosis of primary upper urinary tract cancer after radical nephroureterectomy in taiwanese patients. Eur Urol 2008;54:1127-35.
    Chung SD; Yu HJ; Chueh SC
    Eur Urol; 2009 Apr; 55(4):e69-70; author reply e71. PubMed ID: 18367314
    [No Abstract]   [Full Text] [Related]  

  • 12. Risk factors for intravesical recurrence after surgical management of transitional cell carcinoma of the upper urinary tract.
    Terakawa T; Miyake H; Muramaki M; Takenaka A; Hara I; Fujisawa M
    Urology; 2008 Jan; 71(1):123-7. PubMed ID: 18242379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combining hand assisted laparoscopic nephroureterectomy with cystoscopic circumferential excision of the distal ureter without primary closure of the bladder cuff--is it safe?
    Kurzer E; Leveillee RJ; Bird VG
    J Urol; 2006 Jan; 175(1):63-7; discussion 67-8. PubMed ID: 16406870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant methotrexate, vinblastine, adriamycin, and cisplatin chemotherapy has potential to prevent recurrence of bladder tumors after surgical removal of upper urinary tract transitional cell carcinoma.
    Soga N; Arima K; Sugimura Y
    Int J Urol; 2008 Sep; 15(9):800-3. PubMed ID: 18651862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Ureteral stump after nephrectomy for papillomatosis].
    Adjiman M
    J Urol Nephrol (Paris); 1976; 82 Suppl 2():263-4. PubMed ID: 1031718
    [No Abstract]   [Full Text] [Related]  

  • 16. Re: Recurrence and survival following laparoscopic radical nephroureterectomy with various forms of bladder cuff control.
    Lee LS; Yip SK; Cheng WS
    J Urol; 2006 Jan; 175(1):391-2; author reply 392-3. PubMed ID: 16406949
    [No Abstract]   [Full Text] [Related]  

  • 17. [Metastasis in the residual ureter after 7 years have passed since nephrectomy for adenocarcinoma].
    Averous M; Guiter J; Grasset D
    J Urol Nephrol (Paris); 1976; 82 Suppl 2():294-7. PubMed ID: 1031730
    [No Abstract]   [Full Text] [Related]  

  • 18. Consideration for treatment of upper urinary tract tumors with topical therapy.
    Huffman JL; Morse MJ; Herr HW; Whitmore WF
    Urology; 1985 Oct; 26(4 Suppl):47-50. PubMed ID: 4049628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Transurethral removal of the ureter by the intussusception method in the treatment of renal pelvic and ureteral tumors].
    Matsushita Y; Owari Y; Nozawa T; Katoh T; Obara W; Isurugi K; Ogata M; Fujioka T
    Hinyokika Kiyo; 2000 Apr; 46(4):241-5. PubMed ID: 10845154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Superficial transitional cell carcinoma of the ureteral orifice: higher risk of developing subsequent upper urinary tract tumors.
    Chou EC; Lin AT; Chen KK; Chang LS
    Int J Urol; 2006 Jun; 13(6):682-5. PubMed ID: 16834642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.